FLUAD® is a flu shot designed for adults 65 and older.

FLUAD® (influenza vaccine, adjuvanted) is the first FDA-approved seasonal flu shot that contains an immune-enhancing ingredient.1

FLUAD helps protect against the same flu strains as other seasonal flu shots, but it has something they don’t have: an immune-enhancing ingredient that can help provide a strong immune response to the flu in adults 65 and older.1,2

What is this immune-enhancing ingredient?

The immune-enhancing ingredient in FLUAD is an oil derived from squalene. Squalene is a naturally occurring substance found in humans, animals, and plants.1

Squalene is also found in3:
  • Foods
  • Health supplements
  • Cosmetics
  • Over-the-counter medications
DID YOU KNOW?
Squalene is made by the liver and normally circulates in the human body.3

How is FLUAD different?

An aging immune system may cause adults aged 65 and older to have a lower immune response to traditional flu vaccines compared to younger adults. The immune-enhancing ingredient in FLUAD is proven to provide a strong immune response to help the immune systems of adults 65 and older recognize and respond to the flu.1,4

Isn’t it time you consider a flu shot designed specifically for adults 65 and older?
Ask your doctor or pharmacist for FLUAD.
Next: The FLU at 65+
References: 1. FLUAD™ flu vaccine with adjuvant. Centers for Disease Control and Prevention website. https://www.cdc.gov/flu/protect/vaccine/adjuvant.htm. Updated July 11, 2016. Accessed May 16, 2017. 2. FLUAD [package insert]. Summit, NJ: Seqirus USA Inc; 2017. 3. Squalene-based adjuvants in vaccines. World Health Organization website. http://www.who.int/vaccine_safety/committee/topics/adjuvants/squalene/questions_and_answers/en/. Updated July 21, 2006. Accessed May 22, 2017. 4. O'Hagan D, Ott GS, De Gregorio E, Seubert A. The mechanism of action of MF59 - an innately attractive adjuvant formulation. Vaccine. 2012;30(29):4341-4348. 5. Seqirus Inc. New influenza vaccine offers improved protection for older adults. http://www.seqirus.com/newsroom/New-influenza-vaccine-offers-improved-protection-for-older-adults. Updated 2017. Accessed September 23, 2017. 6. Seqirus Inc. Data on file. Vaccine: V70; Fluad®; aTIV development safety update report. 2016.